Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 63 UNKNOWN 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Paclitaxel 7 Epirubicin 7 Capecitabine 7 pyrotinib 5 Docetaxel 5 Carboplatin 5 Vinorelbine 4 Fulvestrant 4 Cyclophosphamide 4 exemestane 3 anlotinib 3 Radiotherapy 3 Radiation Dose Hypofractionation 3 Etoposide 3 pirarubicin 2 palbociclib 2 apatinib 2 Standard of Care 2 Neoadjuvant Therapy 2 Letrozole 2 Albumin-Bound Paclitaxel 2 toripalimab 1 titanium silicide 1 nimotuzumab 1 neratinib 1 lobaplatin 1 liposomal doxorubicin 1 icaritin 1 eribulin 1 Zoledronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Methods × Breast × Clear all

NCT05068115 2021-10-13

Characteristics and Treatment Trends of Young Breast Cancer in China

ChineseAMS

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡